Naming the problem precisely — because treatment depends on it
Anorgasmia is defined as persistent difficulty or inability to reach orgasm despite adequate stimulation and sufficient arousal, when this causes personal distress. The distress qualifier matters: variable or absent orgasm that a person is at peace with is not a clinical concern. The problem is the combination of difficulty and distress.
Two distinctions drive treatment planning and should be the first questions asked — by your clinician and by you. Lifelong versus acquired: a woman who has never reached orgasm by any means is almost always working with a learning and discovery problem, which is also the most treatable kind. A woman who used to orgasm and has stopped is looking for what changed — usually medication, hormones, mood, relationship dynamics, or health. Global versus situational: orgasm that works in solo self-stimulation but not during partnered sex points squarely at the partnered context — stimulation type, pressure, communication, relational anxiety — rather than at any deficit in the body's capacity. This distinction is practically important because the treatments for these subtypes are different.
The lifelong/acquired and global/situational categories are the standard specifiers for female orgasmic disorder in DSM-5. A clinician who does not ask these questions is not gathering the information that determines which treatment is likely to help.
Rule-outs first — medication, hormones, health
Before any behavioural programme, check the things that a behavioural programme cannot fix. A common identifiable cause of acquired anorgasmia (orgasm that used to work and has stopped) is medication. SSRIs and SNRIs (antidepressants including sertraline, fluoxetine, paroxetine, venlafaxine, and duloxetine) are well documented to delay or block orgasm in some users. If the onset tracks the prescription, discuss it with your prescriber, who can weigh options such as dose adjustment, switching to a different antidepressant, adding another agent, or a planned break if your mental-health stability permits. Do not stop medication on your own.
Other possible contributors: hormonal changes associated with menopause, perimenopause, postpartum recovery, and some hormonal contraception; alcohol and some other substances; depression itself (which can reduce desire and sexual response independent of any medication); and, less commonly, neurological conditions, pelvic surgery, or radiation affecting pelvic nerves.
For lifelong anorgasmia — where orgasm has simply never occurred by any route — the medical layer matters less and the learning and discovery layer matters more, because the issue is typically absence of the right stimulation, information, and conditions rather than any physical impairment. However, pain or numbness alongside warrants medical assessment regardless of which subtype applies.
A GP visit covering current and recent medication, hormonal status, mood, and general health history is the appropriate first move when orgasm has stopped after previously working. It is not the appropriate first move when orgasm has simply never occurred — in which case starting with directed masturbation (below) is reasonable alongside, not after, a medical check.
Directed masturbation: the most-cited treatment for lifelong anorgasmia
The behavioural treatment most often cited as best supported for women who have never reached orgasm is directed masturbation: a structured, progressive self-touch programme described by LoPiccolo and Lobitz in 1972 and set out as a manual in Heiman and LoPiccolo's Becoming Orgasmic (1976, updated editions available). It is also unglamorous: a step-by-step programme of self-exploration and self-stimulation with no goal except building familiarity and sensation.
The programme moves through stages. It begins with visual self-exploration — simply looking at one's own genitalia with a mirror, building comfort and familiarity with anatomy. It progresses to tactile self-exploration: touching the whole body, then specifically the genitalia, to locate areas of sensation without any goal. Then to building and sustaining arousal — allowing arousal to build without immediately redirecting it. Then to using a vibrator, which many women find provides the intensity of stimulation needed for a first orgasm that manual stimulation alone does not. Finally, to transferring the learned response to partnered contexts: guiding a partner's hand, using vibration during partnered sex, building the bridge from solo to shared.
The evidence needs to be stated plainly. The case for directed masturbation rests mainly on older, small studies and reviews (for example Andersen's 1983 review of treatment for primary orgasmic dysfunction), which report high rates of solo orgasm among women who complete programmes and less consistent transfer to partnered sex. Modern controlled evidence is sparse: a 2023 systematic review of treatments for anorgasmia in premenopausal women (Gould and Edney, 15 studies) rated most included studies at very high risk of bias and judged the overall findings inconclusive. So directed masturbation is a long-established, low-risk clinical approach with a plausible rationale (graded practice, accurate information about one's own body, reduced performance pressure), not a treatment with strong modern trial proof.
A note on vibrators: they are commonly included in clinical programmes for anorgasmia rather than treated as a shortcut. For some women, particularly those working toward a first orgasm, vibration provides stimulation intensity that manual touch does not. Some women later expand to other routes; others do not, and neither is a problem.
Sensate focus and couple-based work — for the partnered gap
When orgasm works reliably in solo self-stimulation but not during partnered sex, the treatment target shifts from learning to reach orgasm to allowing orgasm with a partner. These are different problems with different solutions. The principal barrier is usually the performance dimension: partnered sex has become a test with a specific deliverable, and orgasm does not reliably survive being a deliverable. Anxiety, self-monitoring (Masters and Johnson's term 'spectatoring' describes the common pattern of watching yourself from the outside during sex), and communication gaps about what stimulation actually works all maintain the gap.
The canonical tool for this presentation is sensate focus, the staged touch protocol developed by Masters and Johnson and restated for modern clinical practice by Weiner and Avery-Clark. The rationale for anorgasmia is that by removing orgasm as a goal in early stages, it removes the test, lets arousal develop without performance pressure, and gives both partners a structured way to learn what works. Later stages can fold in what directed masturbation has taught, such as partner-guided stimulation and vibration during partnered sex. This rationale is clinical reasoning; sensate focus is widely used, but trial evidence for it specifically in female orgasm difficulties is limited.
Communication work often accompanies sensate focus for women with situational anorgasmia, because stimulation that is not what the person needs can go unsaid. A US probability survey of 1,055 women (Herbenick and colleagues, 2018) found that 18.4% reported intercourse alone was sufficient for orgasm, 36.6% said clitoral stimulation was necessary for orgasm during intercourse, and a further 36% said it was not needed but made orgasms feel better. Many couples have never discussed this explicitly, and saying what works is a practical step rather than an unromantic one.
If the gap between solo and partnered orgasm is large, or if shame, anxiety or relational tension makes couple-based work difficult, a credentialed sex therapist (AASECT-certified in the US, COSRT-registered in the UK, or in Australia a member of a body such as the Society of Australian Sexologists) can provide structure and a professional container for the work.
CBT and mindfulness-based therapy — the attention layer
Two psychological therapies have trial evidence in closely adjacent conditions. Cognitive behavioural therapy targets the cognitive patterns that can interrupt orgasm: spectatoring (self-observation and self-grading mid-sex), shame-laden or catastrophic beliefs about pleasure and the body, and hypervigilance that keeps attention in an evaluative mode rather than a sensory one.
Mindfulness-based therapy approaches the same problem by training present-moment, non-judgemental attention to bodily sensation. Lori Brotto's programme of randomised trials at the University of British Columbia is the largest body of trial evidence in this territory. Her 2025 eSense trial (Mahar, Stephenson and Brotto; Behaviour Research and Therapy) randomised 129 women with sexual interest/arousal disorder to online CBT, online mindfulness-based therapy, or a waitlist. Both active programmes improved desire and arousal (effect sizes above 0.90) and sexual distress compared with the waitlist, with improvements generally maintained at six-month follow-up, and the two programmes did not differ on primary outcomes.
The precision matters for anorgasmia: Brotto's trials targeted desire and arousal difficulties, not anorgasmia as a standalone diagnosis. The mechanism argument for anorgasmia is direct (attention to sensation during sexual response is plausibly what orgasm needs), but direct trial evidence with orgasm as the primary endpoint is thinner than for desire and arousal.
In practice, CBT and mindfulness-based work are most commonly delivered as part of broader sex therapy or combined psychological treatment. They are rarely the standalone treatment; they are the attention and cognition layer that makes the behavioural work (directed masturbation, sensate focus) more effective by removing the mental obstacles that block it.
Where tantric and somatic body-work fits
Tantric and somatic practice comes last here because the evidence for it is weakest. There is no randomised controlled trial of tantric practice for anorgasmia.
What body-based work offers, if anything, is a possible foundation for women who describe a pelvis that feels quiet, numb, or absent from their experience, or attention long trained away from bodily sensation. Some women describe exactly this kind of disconnection, as though the pelvic region is a territory they have never inhabited. Slow, goal-free, attentive practice, such as body mapping or breath-paced exploration, is one structured way of building awareness there. If numbness is new, constant or accompanied by other symptoms, it needs a medical assessment first.
The proposed mechanism overlaps with what mindfulness-based therapy trains: attention directed into present-moment bodily sensation, without evaluation or goal. The pressure-removal overlaps with sensate focus: a context where orgasm is explicitly not the goal, which may let sensation build more freely. For some women, body-mapping may be a format in which they can first practise goal-free attention before more structured clinical programmes. This is a hypothesis drawn from adjacent evidence, not a tested effect.
The honest framing: use it as the ground floor under a proper treatment plan. Not as the plan. Not as a substitute for directed masturbation, medical rule-outs, or seeing a sex therapist if progress stalls. As the patient, daily practice that builds familiarity with your body and its sensation, underneath and supporting the clinical pathway.
A realistic treatment arc — and when to get more help
A sensible sequence, assembled from the sources above (an editorial synthesis, not a validated protocol). Step one: medical rule-outs, especially if orgasm has stopped after previously working. Step two: for lifelong anorgasmia, directed masturbation as the main behavioural approach; for situational anorgasmia (works solo, not partnered), sensate focus plus communication work. Step three, optionally: mindfulness or body-mapping practice as an attentional foundation underneath either pathway. Step four: consider adding a vibrator, which clinical programmes commonly include.
Expect weeks to months, not days; no source cited here gives a reliable timeline. Early signs of progress may look like noticing more sensation during practice, easier arousal, less spectatoring, and less shame about what the body wants. These are worth noticing in their own right, and orgasm is not guaranteed.
Bring in a credentialed sex therapist if solo progress stalls after several months of genuine practice; if shame or trauma history keeps surfacing and blocking progress; if the couple dynamics around the issue have hardened into pressure and failure; or if the medical assessment identified a cause (medication, hormones) that has not been fully addressed.
A realistic base rate: reviews of older studies report high rates of solo orgasm among women who complete directed-masturbation programmes, but the quality of that evidence is limited (see above), and results for partnered orgasm are less consistent. Anorgasmia is generally regarded as treatable, but nothing here is a promise of a particular outcome.
This is not a substitute for medical care
If orgasm has stopped after previously being present, see a GP before beginning any behavioural programme. The cause may be medication, hormonal, mood-related, or neurological — all of which need clinical assessment, not self-treatment. If orgasm has simply never occurred, a medical check is reasonable alongside beginning behavioural work, but is not an urgent first step unless there is pain, numbness, or other physical symptoms present.
A credentialed sex therapist with specific training in female sexual response can add structure and support, particularly when shame, trauma or relationship dynamics are significant. In Australia, a GP can provide a referral to a psychologist under a Mental Health Treatment Plan. The Society of Australian Sexologists and AASECT maintain therapist directories.
If you have a history of sexual trauma, go slowly and involve a trauma-informed clinician before body-based practices; stop any practice that brings up flooding, dissociation or distress. If pain, distress or past experiences ever leave you feeling unsafe or hopeless, speak to a GP or mental-health professional, and see the Safety page (/safety/) for crisis lines in Australia, the UK and the US.